"We have shown that bleeding causes death, and we have shown a striking reduction in bleeding. This was shown in all subgroupsthere was no subgroup in which enoxaparin looked better," Yusuf said. The ...

Presenters: Salim Yusuf, MD, DPhil, and Shamir R. Mehta, MD (McMaster University, Hamilton, Ontario, Canada) Heparin binds to antithrombin III and induces a conformational change, increasing its ...

Please provide your email address to receive an email when new articles are posted on . A 45-day course of rivaroxaban for the treatment of high-risk patients with superficial vein thrombosis did not ...

Patients with acute coronary syndromes (ACS) benefit from antithrombotic therapy, but major bleeding is a worrying complication associated with this treatment. This was a prospective subgroup analysis ...

Recent data have shown that fondaparinux, a selective factor Xa inhibitor, is noninferior to enoxaparin for short-term prevention of adverse cardiovascular outcomes in patients with non-ST-segment ...

Please provide your email address to receive an email when new articles are posted on . Patients with superficial vein thrombosis treated with rivaroxaban experienced similar rates of progression or ...